Present at BIO-Europe Spring® Digital
January 13, 2021
Apply to Present at BIO-Europe Spring® Digital
NEW deadline to apply is January 20.Attracting visibility as a presenting company has never been easier at BIO-Europe Spring Digital! While presenting at a digital event may be different than what you are used to in person, it does provide new opportunities for additional exposure!
Benefits of presenting at BIO-Europe Spring Digital
•Your pre-recorded pitch will be embedded in the high traffic environment of partneringONE® and not stored in a separate content platform. Watching your presentation and requesting a meeting will be conveniently in one place and has never been easier.
•Your pitch will enrich your company profile and gives additional exposure throughout the partnering cycle from as early as four weeks before the event.
•Statistics from this fall’s BIO-Europe Digital show that presenting biotech companies are receiving up to 30% more meeting requests than other attending biotech companies.
•Visibility after the event. All content, including your pitch, will be accessible until June 30, 2021.
Registration Discounts for BIO members
Early Bird Pricing End January 22 + 10% Discount for BIO Members
Register before January 22 to combine the €200 early bird savings with your 10% BIO member discount! Please enter VIP code “21BESVBIOmbr” in the VIP code field during the last step in registration. View Pricing and Learn More →Questions about registering? Please contact Santa Munro, EBD Group for assistance.
Please note: To be eligible for discounts, you must be a BIO member in good standing at the time of registration. View the BIO member directory to confirm your member status.
Recent News
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
- Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies